What was the full cost of the Lasergen program in the Q2 results
? What's your outlook, maybe again? Not asking for guidance by any means, but over the next six months to 12 months, does this have the potential to linger versus some of the other ones that should snapback with?
Mike McMullen -- President and Chief Executive Officer
In my prepared remarks, we basically said we expect this segment to be subdued for the foreseeable future. So it's really just tied to events that I'm just not smart enough to figure out myself, which is when does global growth start to get solidified and when does it start to turn. I think what we wanted to point out, there actually are some little glimmers of positive aspects of C&E business, particularly the COVID-19 has exposed the fragility of the world's supply chain. And we're seeing many customers and many governments, they want certain critical components made in their country and made in their region.
So we are seeing indications across multiple industries of onshoring initiatives actually starting, which would speak to some longer-term growth prospects in this space. But don't get too excited. This -- I would just say, let's assume that it's going to stay subdued for a while, as we're thinking about it right now. Hence, the reason why we went through the guidance in Q2, because some of these are just too difficult to predict the timing of transition.
Robert W. McMahon -- Senior Vice President, Agilent Chief Financial Officer
Yeah. And I would say, Patrick, just on that, obviously, the more subdued piece is the instrumentation...
Mike McMullen -- President and Chief Executive Officer
Yeah, absolutely.
Robert W. McMahon -- Senior Vice President, Agilent Chief Financial Officer
And we will see the snapback or the improvement first in the ACG business.
Mike McMullen -- President and Chief Executive Officer
Yeah. Absolutely.
Patrick Donnelly -- Citi -- Analyst
That's really helpful. And then a very quick cleanup on NASD, following up Tycho's question there. Do you guys have capacity to increase the address demand from COVID or are you already kind of maxed out in terms of the build out and just as you build out capacity, it's kind of addressing?
Mike McMullen -- President and Chief Executive Officer
We are not capacity constrained. And now, we continue to build out the new facility in Frederick as well as optimizing our Boulder facility. And while I can't share specific names, I can tell you that there are programs under way that aren't in the revenue yet right now that are related to COVID-19 work.
Patrick Donnelly -- Citi -- Analyst
Great. Thanks a lot, Mike.
Mike McMullen -- President and Chief Executive Officer
You are quite welcome.
Operator
Our next question comes from the line of Derik de Bruin of Bank of America. Please go ahead. Your line is open.
Mike McMullen -- President and Chief Executive Officer
Hey, Derik.
Derik de Bruin -- Bank of America -- Analyst
Hello. Good afternoon. Hi. Couple of questions, just a couple of cleanups. The NASD base now in 2Q, what's that -- where are we in terms of revenues? That was up 35%. I'm just curious on the base.
Mike McMullen -- President and Chief Executive Officer
Yeah. It's tracking well to the number that we talked about at the -- or what people have estimated, ramping up to $150 million kind of run rate. It's tracking well to that.
Derik de Bruin -- Bank of America -- Analyst
Great. And what are you going to do with the -- are you reinvesting the Lasergen money into the business or is that going to drop through? Are you going to -- and can you remind us on what you were spending on that I think it was around $50-ish million.
Mike McMullen -- President and Chief Executive Officer
Yeah. No, it was about $30 million a year. That was what was kind of forecasted this year. We've spent basically half of that. So the second half of the year, that'll be a combination of reinvesting where appropriate and also managing the dynamic situation that we're in, in terms of COVID-19. Hey, Bob, I think we had the full cost of the program in our Q2 results, in our next quarter results.
Robert W. McMahon -- Senior Vice 
? What's your outlook, maybe again? Not asking for guidance by any means, but over the next six months to 12 months, does this have the potential to linger versus some of the other ones that should snapback with?
Mike McMullen -- President and Chief Executive Officer
In my prepared remarks, we basically said we expect this segment to be subdued for the foreseeable future. So it's really just tied to events that I'm just not smart enough to figure out myself, which is when does global growth start to get solidified and when does it start to turn. I think what we wanted to point out, there actually are some little glimmers of positive aspects of C&E business, particularly the COVID-19 has exposed the fragility of the world's supply chain. And we're seeing many customers and many governments, they want certain critical components made in their country and made in their region.
So we are seeing indications across multiple industries of onshoring initiatives actually starting, which would speak to some longer-term growth prospects in this space. But don't get too excited. This -- I would just say, let's assume that it's going to stay subdued for a while, as we're thinking about it right now. Hence, the reason why we went through the guidance in Q2, because some of these are just too difficult to predict the timing of transition.
Robert W. McMahon -- Senior Vice President, Agilent Chief Financial Officer
Yeah. And I would say, Patrick, just on that, obviously, the more subdued piece is the instrumentation...
Mike McMullen -- President and Chief Executive Officer
Yeah, absolutely.
Robert W. McMahon -- Senior Vice President, Agilent Chief Financial Officer
And we will see the snapback or the improvement first in the ACG business.
Mike McMullen -- President and Chief Executive Officer
Yeah. Absolutely.
Patrick Donnelly -- Citi -- Analyst
That's really helpful. And then a very quick cleanup on NASD, following up Tycho's question there. Do you guys have capacity to increase the address demand from COVID or are you already kind of maxed out in terms of the build out and just as you build out capacity, it's kind of addressing?
Mike McMullen -- President and Chief Executive Officer
 We are not capacity constrained. And now, we continue to build out the new facility in Frederick as well as optimizing our Boulder facility. And while I can't share specific names, I can tell you that there are programs under way that aren't in the revenue yet right now that are related to COVID-19 work.
Patrick Donnelly -- Citi -- Analyst
Great. Thanks a lot, Mike.
Mike McMullen -- President and Chief Executive Officer
You are quite welcome.
Operator
Our next question comes from the line of Derik de Bruin of Bank of America. Please go ahead. Your line is open.
Mike McMullen -- President and Chief Executive Officer
Hey, Derik.
Derik de Bruin -- Bank of America -- Analyst
Hello. Good afternoon. Hi. Couple of questions, just a couple of cleanups. The NASD base now in 2Q, what's that -- where are we in terms of revenues? That was up 35%. I'm just curious on the base.
Mike McMullen -- President and Chief Executive Officer
Yeah. It's tracking well to the number that we talked about at the -- or what people have estimated, ramping up to $150 million kind of run rate. It's tracking well to that.
Derik de Bruin -- Bank of America -- Analyst
Great. And what are you going to do with the -- are you reinvesting the Lasergen money into the business or is that going to drop through? Are you going to -- and can you remind us on what you were spending on that I think it was around $50-ish million.
Mike McMullen -- President and Chief Executive Officer
Yeah. No, it was about $30 million a year. That was what was kind of forecasted this year. We've spent basically half of that. So the second half of the year, that'll be a combination of reinvesting where appropriate and also managing the dynamic situation that we're in, in terms of COVID-19. Hey, Bob, I think we had the full cost of the program in our Q2 results, in our next quarter results.
Robert W. McMahon -- Senior Vice 